Aptose Biosciences Inc.
13F holders, Q2 2024 (June 30)1holders −1
0new positions
1sold out
$0.76avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Aptose Biosciences Inc. in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holder was Caldwell Sutter Capital, Inc. ($70).
- Company
- Aptose Biosciences Inc.
- CUSIP
- 03835T200
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $44K |
All 13F filers, Q1 2024 → Q2 2024: 26,666 shares sold, net −26,666 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 92 | $70 |
"% of holder's portfolio" is APTOSE BIOSCIENCES INC's weight in each manager's 13F, not the share of Aptose Biosciences Inc. the manager owns.